89 related articles for article (PubMed ID: 22669509)
1. IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.
Nakamachi T; Tsuchida M; Kagami N; Yofu S; Wada Y; Hori M; Tsuchikawa D; Yoshikawa A; Imai N; Nakamura K; Arata S; Shioda S
J Mol Neurosci; 2012 Nov; 48(3):518-25. PubMed ID: 22669509
[TBL] [Abstract][Full Text] [Related]
2. Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke.
Fang Y; Ren R; Shi H; Huang L; Lenahan C; Lu Q; Tang L; Huang Y; Tang J; Zhang J; Zhang JH
Aging Dis; 2020 Dec; 11(6):1496-1512. PubMed ID: 33269103
[TBL] [Abstract][Full Text] [Related]
3. Age and Sex-Dependent ADNP Regulation of Muscle Gene Expression Is Correlated with Motor Behavior: Possible Feedback Mechanism with PACAP.
Kapitansky O; Sragovich S; Jaljuli I; Hadar A; Giladi E; Gozes I
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937737
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular Unit as a Source of Ischemic Stroke Biomarkers-Limitations of Experimental Studies and Perspectives for Clinical Application.
Steliga A; Kowiański P; Czuba E; Waśkow M; Moryś J; Lietzau G
Transl Stroke Res; 2020 Aug; 11(4):553-579. PubMed ID: 31701356
[TBL] [Abstract][Full Text] [Related]
5. Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.
Denes V; Geck P; Mester A; Gabriel R
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31540472
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal Expression Changes of PACAP and Its Receptors in Retinal Ganglion Cells After Optic Nerve Crush.
Ye D; Yang Y; Lu X; Xu Y; Shi Y; Chen H; Huang J
J Mol Neurosci; 2019 Jul; 68(3):465-474. PubMed ID: 30415445
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of PACAP in ischemia.
Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
[TBL] [Abstract][Full Text] [Related]
8. PACAP suppresses dry eye signs by stimulating tear secretion.
Nakamachi T; Ohtaki H; Seki T; Yofu S; Kagami N; Hashimoto H; Shintani N; Baba A; Mark L; Lanekoff I; Kiss P; Farkas J; Reglodi D; Shioda S
Nat Commun; 2016 Jun; 7():12034. PubMed ID: 27345595
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide (PACAP) contributes to the proliferation of hematopoietic progenitor cells in murine bone marrow via PACAP-specific receptor.
Xu Z; Ohtaki H; Watanabe J; Miyamoto K; Murai N; Sasaki S; Matsumoto M; Hashimoto H; Hiraizumi Y; Numazawa S; Shioda S
Sci Rep; 2016 Feb; 6():22373. PubMed ID: 26925806
[TBL] [Abstract][Full Text] [Related]
10. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke.
Matsumoto M; Nakamachi T; Watanabe J; Sugiyama K; Ohtaki H; Murai N; Sasaki S; Xu Z; Hashimoto H; Seki T; Miyazaki A; Shioda S
J Mol Neurosci; 2016 Jun; 59(2):270-9. PubMed ID: 26910758
[TBL] [Abstract][Full Text] [Related]
11. Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.
Morara S; Colangelo AM; Provini L
Neural Plast; 2015; 2015():135342. PubMed ID: 26273481
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia.
Feng Q; Wang YI; Yang Y
Exp Ther Med; 2015 May; 9(5):1695-1701. PubMed ID: 26136879
[TBL] [Abstract][Full Text] [Related]
13. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP).
Tsumuraya T; Ohtaki H; Song D; Sato A; Watanabe J; Hiraizumi Y; Nakamachi T; Xu Z; Dohi K; Hashimoto H; Atsumi T; Shioda S
J Neuroinflammation; 2015 Feb; 12():35. PubMed ID: 25889720
[TBL] [Abstract][Full Text] [Related]
14. IL-6 regulation of synaptic function in the CNS.
Gruol DL
Neuropharmacology; 2015 Sep; 96(Pt A):42-54. PubMed ID: 25445486
[TBL] [Abstract][Full Text] [Related]
15. Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway.
Xu H; Xiong C; He L; Wu B; Peng L; Cheng Y; Jiang F; Tan L; Tang L; Tu Y; Yang Y; Liu C; Gao Y; Li G; Zhang C; Liu S; Xu C; Wu H; Li G; Liang S
Inflammation; 2015 Feb; 38(1):327-37. PubMed ID: 25348860
[TBL] [Abstract][Full Text] [Related]
16. PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity.
Miyamoto K; Tsumuraya T; Ohtaki H; Dohi K; Satoh K; Xu Z; Tanaka S; Murai N; Watanabe J; Sugiyama K; Aruga T; Shioda S
J Mol Neurosci; 2014 Nov; 54(3):370-9. PubMed ID: 24907941
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the possible functions of PACAP in human trophoblast cells.
Horvath G; Reglodi D; Brubel R; Halasz M; Barakonyi A; Tamas A; Fabian E; Opper B; Toth G; Cohen M; Szereday L
J Mol Neurosci; 2014 Nov; 54(3):320-30. PubMed ID: 24874580
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide (PACAP) signalling exerts chondrogenesis promoting and protecting effects: implication of calcineurin as a downstream target.
Juhász T; Matta C; Katona É; Somogyi C; Takács R; Gergely P; Csernoch L; Panyi G; Tóth G; Reglődi D; Tamás A; Zákány R
PLoS One; 2014; 9(3):e91541. PubMed ID: 24643018
[TBL] [Abstract][Full Text] [Related]
19. PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.
Wada Y; Nakamachi T; Endo K; Seki T; Ohtaki H; Tsuchikawa D; Hori M; Tsuchida M; Yoshikawa A; Matkovits A; Kagami N; Imai N; Fujisaka S; Usui I; Tobe K; Koide R; Takahashi H; Shioda S
J Mol Neurosci; 2013 Oct; 51(2):493-502. PubMed ID: 23720065
[TBL] [Abstract][Full Text] [Related]
20. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
Brown D; Tamas A; Reglödi D; Tizabi Y
J Mol Neurosci; 2013 Jul; 50(3):600-7. PubMed ID: 23625270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
